Skip to main content

FOXL2NB Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84940

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-84940-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of Human C3orf72. Peptide sequence: PKMCLHMAVRHSKAQKTGPGILQQRQKPPAPRASGGPALLGKRRGCSEAG The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for FOXL2NB Antibody

Western Blot: FOXL2NB Antibody [NBP2-84940]

Western Blot: FOXL2NB Antibody [NBP2-84940]

Western Blot: FOXL2NB Antibody [NBP2-84940] - Host: Rabbit. Target Name: C3orf72. Sample Type: PANC1 Whole Cell lysates. Antibody Dilution: 1.0ug/ml

Applications for FOXL2NB Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: FOXL2NB

Alternate Names

C3orf72, Chromosome 3 Open Reading Frame 72, FLJ43329 Protein, FOXL2 Neighbor, FOXL2 Neighbor Protein

Gene Symbol

FOXL2NB

Additional FOXL2NB Products

Product Documents for FOXL2NB Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for FOXL2NB Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...